Gene · 7292
Papers4,164
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,164
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring CCL11 in breast cancer: unraveling its anticancer potential and immune modulatory effects involving the Akt-S6 signaling. | J Cancer Res Clin Oncol | 2024 | 38305920 | PubTator, text mining | PubMed |
| GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region. | Nat Commun | 2024 | 38296975 | PubTator, text mining | PubMed |
| CaMK4 controls follicular helper T cell expansion and function during normal and autoimmune T-dependent B cell responses. | Nat Commun | 2024 | 38287012 | PubTator, text mining | PubMed |
| Macrophage barrier in the tumor microenvironment and potential clinical applications. | Cell Commun Signal | 2024 | 38279145 | PubTator, text mining | PubMed |
| The characteristics of cerebrospinal fluid tumor microenvironment in a patient with leptomeningeal metastases from cancer of unknown primary. | Genes Dis | 2024 | 38274387 | PubTator, text mining | PubMed |
| Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity. | Nat Commun | 2024 | 38267413 | PubTator, text mining | PubMed |
| Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy. | Molecules | 2024 | 38257366 | PubTator, text mining | PubMed |
| Synergistic Effect of Retinoic Acid and Lactoferrin in the Maintenance of Gut Homeostasis. | Biomolecules | 2024 | 38254678 | PubTator, text mining | PubMed |
| The role of exhausted natural killer cells in the immunopathogenesis and treatment of leukemia. | Cell Commun Signal | 2024 | 38254135 | PubTator, text mining | PubMed |
| Immunological subtyping of salivary gland cancer identifies histological origin-specific tumor immune microenvironment. | NPJ Precis Oncol | 2024 | 38245623 | PubTator, text mining | PubMed |
| i-shaped antibody engineering enables conformational tuning of biotherapeutic receptor agonists. | Nat Commun | 2024 | 38245524 | PubTator, text mining | PubMed |
| Identification of HSP90B1 in pan-cancer hallmarks to aid development of a potential therapeutic target. | Mol Cancer | 2024 | 38243263 | PubTator, text mining | PubMed |
| OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic Target. | Am J Clin Dermatol | 2024 | 38236520 | PubTator, text mining | PubMed |
| Zinc Transporters Serve as Prognostic Predictors and their Expression Correlates with Immune Cell Infiltration in Specific Cancer: A Pan-cancer Analysis. | J Cancer | 2024 | 38230214 | PubTator, text mining | PubMed |
| The roles of tissue resident macrophages in health and cancer. | Exp Hematol Oncol | 2024 | 38229178 | PubTator, text mining | PubMed |
| Construction of an immune-related risk score signature for gastric cancer based on multi-omics data. | Sci Rep | 2024 | 38228846 | PubTator, text mining | PubMed |
| Enhanced detection of antigen-specific T cells by a multiplexed AIM assay. | Cell Rep Methods | 2024 | 38228152 | PubTator, text mining | PubMed |
| An Engineered Influenza a Virus Expressing the Co-Stimulator OX40L as an Oncolytic Agent Against Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2024 | 38223555 | PubTator, text mining | PubMed |
| PIEZO2 expression is an independent biomarker prognostic for gastric cancer and represents a potential therapeutic target. | Sci Rep | 2024 | 38216574 | PubTator, text mining | PubMed |
| Integrated Bulk and Single-cell RNA Sequencing Data Constructs and Validates a Prognostic Model for Non-small Cell Lung Cancer. | J Cancer | 2024 | 38213729 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7292/papers?page=13